Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
395,430
-
Shares change
-
+369,202
-
Total reported value, excl. options
-
$10,023,000
-
Value change
-
+$10,016,000
-
Number of buys
-
11
-
Number of sells
-
-1
-
Price
-
$24.01
Significant Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q1 2018
12 filings reported holding RKDA - Arcadia Biosciences, Inc. - Common Stock as of Q1 2018.
Arcadia Biosciences, Inc. - Common Stock (RKDA) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 395,430 shares
of 1,390,020 outstanding shares and own 28% of the company stock.
Largest 10 shareholders include Hudson Bay Capital Management LP (150,376 shares), SABBY MANAGEMENT, LLC (150,376 shares), RENAISSANCE TECHNOLOGIES LLC (44,225 shares), PAPP L ROY & ASSOCIATES (18,542 shares), Squarepoint Ops LLC (16,600 shares), BANK OF MONTREAL /CAN/ (10,000 shares), WELLS FARGO & COMPANY/MN (2,908 shares), UBS Group AG (1,159 shares), BARCLAYS PLC (1,000 shares), and BlackRock Inc. (219 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.